S-1 is an active anticancer agent for advanced thymic carcinoma.

@article{Okuma2010S1IA,
  title={S-1 is an active anticancer agent for advanced thymic carcinoma.},
  author={Yusuke Okuma and Tsuneo Shimokawa and Yusuke Takagi and Yukio Hosomi and Mari Iguchi and Tatsuru Okamura and Masahiko Shibuya},
  journal={Lung cancer},
  year={2010},
  volume={70 3},
  pages={357-63}
}
BACKGROUND Thymic carcinoma is a rare intrathoracic malignant tumor, and the prognosis for patients with advanced stage of the disease is poor. However, no definitive chemotherapeutic regimen has been established for advanced thymic carcinoma in front-line settings. The efficacy and benefit of second-line or salvage chemotherapy are also unknown, as few… CONTINUE READING